Literature DB >> 3701044

Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.

R M Anderson, B T Grenfell.   

Abstract

The paper examines predictions of the impact of various one-, two- and three-stage vaccination policies on the incidence of congenital rubella syndrome (CRS) in the United Kingdom with the aid of a mathematical model of the transmission dynamics of rubella virus. Parameter estimates for the model are derived from either serological data or case notifications, and special attention is given to the significance of age-related changes in the rate of exposure to rubella infection and heterogeneous mixing between age groups. Where possible, model predictions are compared with observed epidemiological trends. The principal conclusion of the analyses is that benefit is to be gained in the UK, both in the short and long term, by the introduction of a multiple-stage vaccination policy involving high levels of vaccination coverage of young male and female children (at around two years of age) and teenage girls (between the ages of 10-15 years), plus continued surveillance and vaccination of adult women in the child-bearing age classes. Model predictions suggest that to reduce the incidence of CRS in future years, below the level generated by a continuation of the current UK policy (the vaccination of teenage girls), would require high rates of vaccination (greater than 60%) of both boys and girls at around two years of age. Numerical studies also suggest that uniform vaccination coverage levels of greater than 80-85% of young male and female children could, in the long term (40 years or more), eradicate rubella virus from the population. The robustness of these conclusions with respect to the accuracy of parameter estimates and various assumptions concerning the pattern of age-related change in exposure to infections and 'who acquires infection from whom' is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701044      PMCID: PMC2129652          DOI: 10.1017/s0022172400066079

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  20 in total

1.  Measles antibodies in the population of New Haven, Connecticut.

Authors:  F L BLACK
Journal:  J Immunol       Date:  1959-07       Impact factor: 5.422

2.  The occurrence of neutralizing and complement fixing antibodies in rubella.

Authors:  A M Field
Journal:  J Hyg (Lond)       Date:  1967-09

3.  Two-stage vaccination programme against rubella.

Authors:  R M Anderson; R M May
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

Review 4.  Measles and rubella in the United States.

Authors:  H W Hethcote
Journal:  Am J Epidemiol       Date:  1983-01       Impact factor: 4.897

5.  Vaccination against rubella and measles: quantitative investigations of different policies.

Authors:  R M Anderson; R M May
Journal:  J Hyg (Lond)       Date:  1983-04

6.  Measles in England and Wales--I: An analysis of factors underlying seasonal patterns.

Authors:  P E Fine; J A Clarkson
Journal:  Int J Epidemiol       Date:  1982-03       Impact factor: 7.196

7.  Measles in England and Wales--II: The impact of the measles vaccination programme on the distribution of immunity in the population.

Authors:  P E Fine; J A Clarkson
Journal:  Int J Epidemiol       Date:  1982-03       Impact factor: 7.196

8.  Consequences of confirmed maternal rubella at successive stages of pregnancy.

Authors:  E Miller; J E Cradock-Watson; T M Pollock
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

9.  Directly transmitted infections diseases: control by vaccination.

Authors:  R M Anderson; R M May
Journal:  Science       Date:  1982-02-26       Impact factor: 47.728

10.  Rubella vaccination: persistence of antibodies for up to 16 years.

Authors:  S O'Shea; J M Best; J E Banatvala; W C Marshall; J A Dudgeon
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24
View more
  28 in total

1.  Health professionals do not understand mathematical models.

Authors:  W J Edmunds; N J Gay
Journal:  BMJ       Date:  2000-02-26

2.  The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster.

Authors:  G P Garnett; B T Grenfell
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

3.  Serological study of the epidemiology of mumps virus infection in north-west England.

Authors:  D J Nokes; J Wright; P Morgan-Capner; R M Anderson
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

4.  Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.

Authors:  N J Gay; L M Hesketh; P Morgan-Capner; E Miller
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

5.  Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.

Authors:  L Matter; D Germann; F Bally; K Schopfer
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

Review 6.  The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes.

Authors:  D J Nokes; R M Anderson
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

7.  Seroepidemiological study of the transmission of the mumps virus in St. Lucia, West Indies.

Authors:  M J Cox; R M Anderson; D A Bundy; D J Nokes; J M Didier; I Simmons; J St Catherine
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

8.  Reply: Say Yes and No to MMR; 'Theory of Relativity'!!

Authors:  A Banerjee
Journal:  Med J Armed Forces India       Date:  2011-07-21

9.  A mathematical model to study the effect of hepatitis B virus vaccine and antivirus treatment among the Canadian Inuit population.

Authors:  C O'Leary; Z Hong; F Zhang; M Dawood; G Smart; K Kaita; J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-12       Impact factor: 3.267

10.  Ecological theory to enhance infectious disease control and public health policy.

Authors:  Katherine F Smith; Andrew P Dobson; F Ellis McKenzie; Leslie A Real; David L Smith; Mark L Wilson
Journal:  Front Ecol Environ       Date:  2005-02-01       Impact factor: 11.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.